Our top pick for
Sharps Compliance Corp is a waste management business based in the US. Sharps Compliance shares (SMED) are listed on the NASDAQ and all prices are listed in US Dollars. Sharps Compliance employs 190 staff and has a trailing 12-month revenue of around 0.00.
|Latest market close||$8.00|
|52-week range||$5.45 - $18.15|
|50-day moving average||$8.45|
|200-day moving average||$11.32|
|Wall St. target price||$16.00|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$0.76|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|1 week (2021-10-15)||0.50%|
|1 month (2021-09-24)||-6.76%|
|3 months (2021-07-23)||-14.35%|
|6 months (2021-04-23)||-49.69%|
|1 year (2020-10-23)||31.58%|
|2 years (2019-10-23)||67.01%|
|3 years (2018-10-23)||125.35%|
|5 years (2016-10-21)||87.79%|
Valuing Sharps Compliance stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Sharps Compliance's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Sharps Compliance's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 10x. In other words, Sharps Compliance shares trade at around 10x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
Sharps Compliance's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 2.49. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Sharps Compliance's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Sharps Compliance's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $14.3 million.
The EBITDA is a measure of a Sharps Compliance's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||$76.4 million|
|Operating margin TTM||16.1%|
|Gross profit TTM||$28.9 million|
|Return on assets TTM||11.87%|
|Return on equity TTM||33.79%|
|Market capitalisation||$153.7 million|
TTM: trailing 12 months
There are currently 875,849 Sharps Compliance shares held short by investors – that's known as Sharps Compliance's "short interest". This figure is 0.3% up from 873,234 last month.
There are a few different ways that this level of interest in shorting Sharps Compliance shares can be evaluated.
Sharps Compliance's "short interest ratio" (SIR) is the quantity of Sharps Compliance shares currently shorted divided by the average quantity of Sharps Compliance shares traded daily (recently around 153388.61646235). Sharps Compliance's SIR currently stands at 5.71. In other words for every 100,000 Sharps Compliance shares traded daily on the market, roughly 5710 shares are currently held short.
However Sharps Compliance's short interest can also be evaluated against the total number of Sharps Compliance shares, or, against the total number of tradable Sharps Compliance shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Sharps Compliance's short interest could be expressed as 0.05% of the outstanding shares (for every 100,000 Sharps Compliance shares in existence, roughly 50 shares are currently held short) or 0.0614% of the tradable shares (for every 100,000 tradable Sharps Compliance shares, roughly 61 shares are currently held short).
A SIR below 10% would generally be considered to indicate a fairly optimistic outlook for the share price, with fewer people currently willing to bet against Sharps Compliance.
Find out more about how you can short Sharps Compliance stock.
We're not expecting Sharps Compliance to pay a dividend over the next 12 months.
Sharps Compliance's shares were split on a 5:4 basis on 23 July 1998. So if you had owned 4 shares the day before before the split, the next day you'd have owned 5 shares. This wouldn't directly have changed the overall worth of your Sharps Compliance shares – just the quantity. However, indirectly, the new 20% lower share price could have impacted the market appetite for Sharps Compliance shares which in turn could have impacted Sharps Compliance's share price.
Over the last 12 months, Sharps Compliance's shares have ranged in value from as little as $5.445 up to $18.15. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Sharps Compliance's is -0.227. This would suggest that Sharps Compliance's shares have been inversely-correlated to the average (for this exchange) – so when the broader market trended up or down, Sharps Compliance has bucked the trend.
Sharps Compliance Corp. provides medical, pharmaceutical, and hazardous waste management services in the United States. It offers Sharps Recovery System for the containment, transportation, treatment, and tracking of medical waste generated outside the hospital and health care facility settings; TakeAway Recovery System to treat used needles, syringes, and other used healthcare products; Route-Based Pickup Service, a medical and hazardous waste pick-up services; and MedSafe, a solution for the safe collection, transportation, and disposal of unwanted and expired ultimate-user medications. The company also provides TakeAway Medication Recovery System that facilitates the proper disposal of unused medications; Black Pail Program for Rx, a solution with minimal segregation for the disposal of various pharmaceuticals; Inhaler Disposal to collect, transport, and destroy used pharmaceutical inhalers; Hazardous Drug Spill Control Kit for the cleanup of chemotherapy and other HD spills; TakeAway Recycle System for the collection and recycling of single-use medical devices from surgical centers and other healthcare facilities; ComplianceTRAC, a Web-based compliance and training program; and Universal Waste Shipback Systems to collect, transport, and recycle light bulbs, batteries, and other mercury containing devices. In addition, it offers other solutions, such as TakeAway Environmental Return System, SharpsTracer, Sharps Secure, Needle Disposal System, Complete Needle Collection and Disposal System, Pitch-It IV Poles, Asset Return System, and Spill Kit Recovery System, as well as Sharps MWMS, a medical waste management system. The company serves customers in home health care, retail clinics and immunizing pharmacies, pharmaceutical manufacturers, professional offices, assisted living and long-term care facilities, and government agencies, as well as distributors. Sharps Compliance Corp.
Steps to owning and managing ProShares Bitcoin Strategy ETF units.
Everything we know about the The Real Good Food Company IPO, plus information on how to buy in.
Everything we know about the Lulu’s Fashion Lounge Holdings IPO, plus information on how to buy in.
Everything we know about the Allarity Therapeutics IPO, plus information on how to buy in.
Everything we know about the Jupiter Neurosciences IPO, plus information on how to buy in.
Everything we know about the Mainz Biomed IPO, plus information on how to buy in.
Everything we know about the Progressive Care IPO, plus information on how to buy in.
Everything we know about the Desert Peak Minerals IPO, plus information on how to buy in.
Everything we know about the Vaxxinity IPO, plus information on how to buy in.
Everything we know about the Entrada Therapeutics IPO, plus information on how to buy in.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.